Bio-Rad Laboratories, Inc (BIO) Stock Price

280.21 ▼ -0.13 (-0.05%)
Open: 280.92 Vol: 203.57K Day's range: 277.40 - 282.21 Sep 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 279.86▲ 279.96▲ 279.42▲ 281.86▼ 291.54▼
MA10 280.07▲ 279.26▲ 279.92▲ 286.33▼ 280.27▼
MA20 279.81▲ 279.99▲ 281.32▼ 289.58▼ 258.82▲
MA50 279.24▲ 281.22▼ 285.38▼ 271.97▲ 286.61▼
MA100 280.09▲ 285.76▼ 288.89▼ 254.22▲ 299.04▼
MA200 281.15▼ 289.77▼ 284.55▼ 277.01▲ 390.14▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.022▲ 0.232▲ 0.165▲ -2.861▼ 5.871▲
RSI 60.090▲ 50.288▲ 45.743▼ 48.186▼ 52.871▲
STOCH 47.174     55.906     30.351     26.699     78.734    
WILL %R -13.333▲ -41.956     -51.486     -84.834▼ -32.964    
CCI 48.593     34.425     -15.158     -122.876▼ 43.989    
Latest Filters Detected On BIO
CDL $BIO Matching Low Candlestick Pattern Detected Set Alert
CDL $BIO Doji Candlestick Pattern Detected Set Alert
Bio-Rad Laboratories, Inc News
LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)
Monday, September 15, 2025 03:23 PM
BOCA RATON, FL / ACCESS Newswire / September 15, 2025 / For most small-cap biotechs, the summer months mean quiet trial work and the occasional conference slide deck. LIXTE Biotechnology Holdings ...
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
Monday, September 15, 2025 10:41 AM
Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...
Nuvation Bio: A Rare Gem In The Risky Biotech Space
Monday, September 15, 2025 09:26 AM
Nuvation Bio stands out as a biotech investment after FDA approval of IBTROZI for ROS1+ NSCLC. Click here to read an analysis of NUVB stock now.
BIO historical stock data
date open high low close volume
15/09/25 280.92 282.21 277.40 280.21 203,565
12/09/25 284.55 285.45 278.635 280.34 242,384
11/09/25 280.29 286.49 278.225 285.90 168,499
10/09/25 284.88 287.9425 276.52 276.91 230,130
09/09/25 292.31 292.31 285.75 285.95 231,851
08/09/25 293.44 293.44 286.37 290.38 192,612
05/09/25 289.43 298.00 289.43 295.43 257,890
04/09/25 286.83 290.72 278.775 289.43 187,656
03/09/25 288.50 291.17 286.33 288.05 202,265
02/09/25 293.83 296.405 286.89 290.71 215,809
Quote Details
52wk Low:211.43
52wk High:387.99
Vol:203.57K
Avg Vol(3m):4.8M
1Y Chng:-16.25%
1M Chng:+1.23%
Add to Watch List
More Information
Index N/A
Market Cap. 7.47B